Canada - English - Health Canada

jamp pharma corporation - vancomycin (vancomycin hydrochloride) - powder for solution - 500mg - vancomycin (vancomycin hydrochloride) 500mg - glycopeptides

Canada - English - Health Canada

jamp pharma corporation - vancomycin (vancomycin hydrochloride) - powder for solution - 1g - vancomycin (vancomycin hydrochloride) 1g - glycopeptides

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin hydrochloride, quantity: 128 mg (equivalent: vancomycin, qty 125 mg) - capsule - excipient ingredients: iron oxide red; gelatin; indigo carmine; titanium dioxide; macrogol 6000; iron oxide yellow - this product accepted for registration as 'currently supplied' at the time of commencement of the act. revisions of product information was approved as specified in the letter of 13 august 1992 from dr alex proudfoot advising of approval for registration of the goods. indicated for the treatment of staphylococcal enterocolitis and antibiotic - associated pseudomembranous colitis produced by c. difficile.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin hydrochloride, quantity: 256 mg (equivalent: vancomycin, qty 250 mg) - capsule - excipient ingredients: iron oxide black; titanium dioxide; indigo carmine; iron oxide red; gelatin; macrogol 6000 - this product accepted for registration as 'currently supplied' at the time of commencement of the act. revision of product information was approved as specified in the letter of 13 august 1992 from dr alex proudfoot advising of approval for registration of the goods. indicated for staphylococcal enterocolitis and antibiotic - associated pseudomembranous colitis produced by c. difficile.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

eli lilly and company - vancomycin - powder for solution for injection/infusion - 50 mg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - vancomycin hydrochloride - powder for solution for infusion - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - vancomycin hydrochloride - powder for solution for infusion - 1gram

United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 125 mg - vancocin is indicated for the treatment of clostridioides difficil e-associated diarrhea. vancocin is also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients less than 18 years of age. limitations of use to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancocin and other antibacterial drugs, vancocin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. vancocin is contraindicated in patients with known hypersensitivity to vancomycin. risk summary systemic absorption of vancomycin is low following oral administration of vancocin; however, absorpt

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

spodefell ltd - vancomycin hydrochloride - powder - 1mg/1mg